Androgenic Hair Patterns Not Linked to Prostate Cancer Risk in South Indian Men: Study
Androgenic phenotypes lack diagnostic utility for prostate cancer screening, with malignancy status accounting for a negligible 1.5% and 1.1% of the variance in scalp baldness and excessive body hair, respectively, as a March 2026 study in the Journal of the Association of Physicians of India has shown.
PCa represents a significant global health burden and is the second most common cancer among men in India, yet a critical clinical gap remains regarding whether physical androgenic traits—which have shown conflicting associations with cancer risk in various Western cohorts—can serve as reliable diagnostic markers in Dravidian men who may possess distinct genetic profiles and androgen receptor (AR) polymorphisms. To address this uncertainty, Jayaprakash Narayanan from the Department of Urology at KAP Viswanatham Government Medical College and his colleagues conducted a rigorous case-control study to evaluate whether androgenic hypertrichosis and androgenetic alopecia (AGA) are effectively linked to PCa in this specific South Indian population.
Therefore, the age-stratified, population-based case-control study was conducted in the Cauvery Delta region, involving a sample size of 117 men with histopathologically confirmed PCa and 123 age-matched controls diagnosed with benign prostatic hyperplasia (BPH) between 2010 and 2015. Through structured face-to-face interviews and direct clinical observations, the investigators excluded non-Dravidian ancestry and analyzed primary endpoints using multivariate linear discriminant analysis and chi-square tests to quantify the strength of association between these hair phenotypes and oncological status.
Key Clinical Findings of the Study Include:
Hypertrichosis Prevalence: Investigation revealed a virtually identical 6% prevalence of excessive body hair in both the PCa group and the BPH control group, suggesting no diagnostic utility.
Alopecia Frequency: Evaluation showed that scalp baldness occurred in 23% of oncology cases compared to 24% of those with BPH, indicating no significant clinical difference between the two cohorts.
Variance Analysis: Analysis demonstrated that these hair traits explained a minimal 1.1% to 1.5% of the diagnostic variance, which confirms that such phenotypes lack substantial predictive power for malignancy.
Pattern Distribution: Assessment confirmed that although vertex baldness was the most common phenotype observed in both groups, it did not successfully distinguish malignant from benign prostatic conditions.
Trait Independence: Study results indicated that both scalp thinning and body hair patterns remain statistically independent of PCa status among the Dravidian men of the Cauvery Delta.
The results suggest that AGA and hypertrichosis are not associated with PCa status in South Indian men, as the prevalence of these traits was remarkably similar between cases and controls.
Thus, the study concludes clinicians practicing in South Indian regions should recognize that visible androgenic traits such as male-pattern baldness or excessive body hair may not be dependable indicators for assessing a patient's risk of developing PCa.
Although the study's moderate sample size and focus on a specific geographical region are limiting factors, future research incorporating diverse cohorts and genetic markers like 5α-reductase expression is necessary to further clarify these interethnic variations.
Reference
Narayanan J, Sundar VE, Mathi SA. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. J Assoc Physicians India 2026;74(3):42–45.
